Skip to content

New Dimension in Chromatography - Halo® 1.5

Improve Your Analyses of Large Proteins, Antibodies and Antibody-Drug Conjugates Using Reversed-Phase Liquid Chromatography by Maximizing Pore Access

protein analysis with reversed phase liquid chromatography

Bonded Phase: C4

Document Type: White Paper

Market Segment: Biopharmaceuticals

Particle Size: 2.7 µm

Pore Size: 1000 Å

Product Segment: BIOCLASS

Separation Mode: Reversed Phase

USP Number: L26

Download File
Back To Top